Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06015126
Status:
RECRUITING
Last Update Posted:
2023-08-29
First Post:
2023-08-08
Brief Title:
Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Sponsor:
Organization:
Xian International Medical Center Hospital